SCHEMBL15838856

SCHEMBL15838856

CC(C)(c1ccc(C(C)(C)c2cc(P)c(OCC3CO3)c(P)c2)cc1)c1cc(P)c(OCC2CO2)c(P)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
TSHR P16473 4/20 0.63
TP53 P04637 3/20 0.63
MAPT P10636 2/20 0.63
HPGD P15428 2/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
HIF1A Q16665 2/20 0.63
CYP1A2 P05177 1/20 0.63
PPARG P37231 1/20 0.63
CYP3A4 P08684 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GLA P06280 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
PKM P14618 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.34
VDR P11473 1/20 0.33
ESR1 P03372 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009409 0.89 TP53 (0.51) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL15835600 0.86 TSHR (0.69) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL15835640 0.85 TSHR (0.63) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL15838929 0.82 ALDH1A1 (0.63) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL19880341 0.82 ALDH1A1 (0.63) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL19880357 0.82 ALDH1A1 (0.63) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL9502828 0.81 ALDH1A1 (0.61) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL2830269 0.81 ALDH1A1 (0.60) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL7139031 0.80 ALDH1A1 (0.55) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL15934083 0.80 ALDH1A1 (0.90) ALDH1A1TSHRTP53MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896535-B2 Epoxy compound having alkoxysilyl group, method of preparing the same, composition and cured product comprising the same, and uses thereof KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2018-02-20 US disclosed
US-9150686-B2 Epoxy compound having alkoxysilyl group, method of preparing the same, composition and cured product comprising the same, and uses thereof KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2015-10-06 US disclosed
US-20150148452-A1 COMPOSITION AND CURED ARTICLE COMPRISING INORGANIC PARTICLES AND EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2015-05-28 US disclosed
EP-2873672-A1 COMPOSITION AND CURED ARTICLE COMPRISING INORGANIC PARTICLES AND EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP Korea Institute of Industrial Technology (KR) 2015-05-20 EP disclosed
US-20140179836-A1 EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148452-A1 COMPOSITION AND CURED ARTICLE COMPRISING INORGANIC PARTICLES AND EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP ELL, ELOC, CCT5 ALDH1A1 2125/4885TSHR 4611/4885TP53 4332/4885
US-20140179836-A1 EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF PFAS, FAR1, ELOVL1 ALDH1A1 302/4885TSHR 2927/4885TP53 4282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.